Xtant Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Xtant Medical Holdings
XTNT Stock  USD 0.71  0.04  5.33%   
Analyzing historical trends in various income statement and balance sheet accounts from Xtant Medical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Xtant Medical's valuation are summarized below:
Gross Profit
82.5 M
Profit Margin
0.0132
Market Capitalization
99.4 M
Enterprise Value Revenue
0.9518
Revenue
133.1 M
There are currently one hundred twenty fundamental gauges for Xtant Medical Holdings that can be evaluated and compared over time across peers. All traders should confirm Xtant Medical's prevalent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 106.7 M in 2026, whereas Market Cap is likely to drop slightly above 37.7 M in 2026.

Xtant Medical Total Revenue

141.6 Million

Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 141.6 M or Gross Profit of 82.4 M, as well as many indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0 or PTB Ratio of 1.51. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
Build AI portfolio with Xtant Stock
Check out the analysis of Xtant Medical Correlation against competitors.

Xtant Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets62.5 M107.9 M65.3 M
Slightly volatile
Total Current Liabilities16.9 M32.9 M17.1 M
Slightly volatile
Accounts Payable5.1 M9.1 M5.2 M
Slightly volatile
Cash5.8 M7.1 M6 M
Slightly volatile
Cash And Short Term Investments5.8 M7.1 M6 M
Slightly volatile
Net Receivables24.9 M23.8 M12.1 M
Slightly volatile
Common Stock Shares Outstanding161.4 M153.7 M47.9 M
Slightly volatile
Liabilities And Stockholders Equity62.5 M107.9 M65.3 M
Slightly volatile
Inventory46.7 M44.4 M21.8 M
Slightly volatile
Other Stockholder Equity365.6 M348.1 M172.9 M
Slightly volatile
Total Liabilities60.5 M58.5 M60.7 M
Very volatile
Total Current Assets81 M77.2 M41 M
Slightly volatile
Short and Long Term Debt Total49.4 M40.4 M47.4 M
Very volatile
Property Plant And Equipment Net8.1 M12.6 M8 M
Slightly volatile
Current Deferred Revenue6.5 M7.6 M6.4 M
Slightly volatile
Non Current Assets Total28.2 M30.7 M27.3 M
Very volatile
Non Currrent Assets Other88.1 K92.7 K1.2 M
Slightly volatile
Common Stock Total Equity1.711.811.5594
Slightly volatile
Non Current Liabilities Total46.3 M25.6 M43.8 M
Very volatile
Property Plant And Equipment Gross37.2 M35.4 M13.2 M
Slightly volatile
Short Term Debt15.6 M14.8 M5.6 M
Slightly volatile
Intangible Assets7.8 M9.6 M7.7 M
Very volatile
Common Stock1.711.844.4418
Slightly volatile
Other Assets0.860.91.2 M
Slightly volatile
Long Term Debt50.6 M25.3 M43 M
Very volatile
Property Plant Equipment7.6 M6.7 M6.8 M
Very volatile
Other Liabilities5.3 M5.7 M6.4 M
Slightly volatile
Short and Long Term Debt10.4 M10.9 M21.1 M
Very volatile
Long Term Debt Total8.3 M8.7 M67.2 M
Slightly volatile
Capital Surpluse177 M319.5 M168.6 M
Slightly volatile
Capital Lease Obligations1.5 M1.1 M1.3 M
Slightly volatile
Net Invested Capital58.1 M88.7 M66.2 M
Slightly volatile
Net Working Capital29.2 M44.3 M22.5 M
Slightly volatile

Xtant Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue141.6 M134.9 M67.8 M
Slightly volatile
Gross Profit82.4 M78.4 M41.5 M
Slightly volatile
Other Operating Expenses156.2 M148.7 M75.2 M
Slightly volatile
Cost Of Revenue59.2 M56.4 M26.3 M
Slightly volatile
Total Operating Expenses97 M92.3 M48.9 M
Slightly volatile
Depreciation And Amortization3.2 M4.9 M3.1 M
Slightly volatile
Selling General Administrative34.6 M33 M16.5 M
Slightly volatile
Selling And Marketing Expenses29.3 M56.6 M28.5 M
Slightly volatile
Non Recurring61.7 M58.8 M30.1 M
Slightly volatile
Reconciled Depreciation3 M3.8 M5.6 M
Slightly volatile

Xtant Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow5.5 M6.8 M5.7 M
Slightly volatile
End Period Cash Flow5.9 M7.2 M6.1 M
Slightly volatile
Stock Based Compensation5 M4.7 M1.9 M
Slightly volatile
Depreciation3.2 M4.9 M3.2 M
Slightly volatile
Cash Flows Other Operating425.8 K448.2 K4.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.550.5813.8717
Slightly volatile
Days Sales Outstanding73.2773.9564.9045
Very volatile
Average Payables9.4 M8.9 M7.6 M
Slightly volatile
Stock Based Compensation To Revenue0.03710.04040.0343
Slightly volatile
Capex To Depreciation0.911.120.8333
Very volatile
EV To Sales0.820.8614.4333
Slightly volatile
Inventory Turnover2.111.462.066
Slightly volatile
Days Of Inventory On Hand378331305
Pretty Stable
Payables Turnover3.945.585.2978
Slightly volatile
Sales General And Administrative To Revenue0.320.280.2871
Slightly volatile
Average Inventory11.6 M17.8 M17.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.02620.02340.0228
Pretty Stable
Capex To Revenue0.03310.04030.0295
Very volatile
Cash Per Share0.05070.05332.5785
Slightly volatile
Days Payables Outstanding11267.7685.4134
Slightly volatile
Intangibles To Total Assets0.130.150.1672
Very volatile
Current Ratio1.742.112.2815
Slightly volatile
Receivables Turnover4.685.115.9332
Pretty Stable
Capex Per Share0.03360.03541.1766
Slightly volatile
Average Receivables4.5 M8.9 M8 M
Slightly volatile
Revenue Per Share0.961.0131.8387
Slightly volatile
Interest Debt Per Share0.320.3434.3988
Slightly volatile
Debt To Assets0.540.340.6801
Pretty Stable
Graham Number0.180.210.2275
Slightly volatile
Operating Cycle452405370
Pretty Stable
Days Of Payables Outstanding11267.7685.4134
Slightly volatile
Ebt Per Ebit1.581.211.892
Very volatile
Long Term Debt To Capitalization0.370.390.8715
Pretty Stable
Total Debt To Capitalization0.490.520.9415
Slightly volatile
Quick Ratio0.860.91.1473
Pretty Stable
Cash Ratio0.330.20.441
Pretty Stable
Cash Conversion Cycle339337284
Slightly volatile
Days Of Inventory Outstanding378331305
Pretty Stable
Days Of Sales Outstanding73.2773.9564.9045
Very volatile
Fixed Asset Turnover5.949.637.6374
Slightly volatile
Debt Ratio0.540.340.6801
Pretty Stable
Price Sales Ratio0.550.5813.8717
Slightly volatile
Asset Turnover1.31.441.239
Pretty Stable
Gross Profit Margin0.490.520.5852
Very volatile

Xtant Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap37.7 M53.3 M48.1 M
Very volatile
Enterprise Value106.7 M101.4 M92.6 M
Very volatile

Xtant Fundamental Market Drivers

Xtant Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue7.6 M6.5 M
Total Revenue134.9 M141.6 M
Cost Of Revenue56.4 M59.2 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 0.28  0.32 
Research And Ddevelopement To Revenue 0.02  0.03 
Capex To Revenue 0.04  0.03 
Revenue Per Share 1.01  0.96 
Ebit Per Revenue(0.09)(0.10)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY